▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Cellarity to Present at 44th Annual J.P. Morgan Healthcare Conference

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that Chief Executive Officer Ted Myles will...

Immagine

Company to highlight outlook for pipeline and platform momentum in 2026

SOMERVILLE, Mass.: Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that Chief Executive Officer Ted Myles will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:00 a.m. PST. The presentation will update on the progress of Cellarity’s innovative Cell State-Correcting platform and pipeline, including its clinical program CLY-124, a first-in-class oral globin-switching investigational therapy for sickle cell disease (SCD).

About Cellarity

Founded by Flagship Pioneering in 2019, Cellarity is pioneering a fundamentally new approach to drug discovery that corrects whole cell-state dysfunction to solve complex diseases. The Company’s proprietary drug discovery platform leverages advanced transcriptomics to comprehensively understand gene networks and applies the power of dynamic AI modeling to predict and design oral Cell State-Correcting therapeutics that can precisely regulate genetic switch mechanisms to restore proper cell function. The Company’s lead asset, CLY-124, is designed to treat sickle cell disease through a novel globin-switching mechanism and is under evaluation in a Phase 1 clinical study. Additional candidates designed by the platform are advancing for indications in hematology and immunology, and Cellarity has an active collaboration with Novo Nordisk targeting metabolic dysfunction-associated steatohepatitis (MASH). For more information visit www.cellarity.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

KNIME Enters Into Next Phase of Growth With the Appointment of Trevor…

Today KNIME announced that Michael Berthold, Founder and CEO, is stepping down from the role. Trevor Kaufman, a seasoned CEO with a proven track record…

Qnity Announces CFO Transition

Qnity Electronics, Inc. (“Qnity”) (NYSE: Q), a premier technology solutions leader across the semiconductor value chain, today announced that Matt Harbaugh…

Skild AI Raises $1.4B, Now Valued Over $14B

Skild AI, an AI robotics company building a scalable foundation model for robotics, today announced it has raised close to $1.4 billion in funding led…

Flip Hits 300M Automated Call Milestone, Raises $20M to Scale Enterprise…

Flip, the AI solution that automates customer service calls for enterprise brands, today announced a $20 million Series A funding round co-led by Next…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!